首页> 外国专利> ADSORPTION AGENTS FOR ORAL ADMINISTRATION, MEANS FOR THE TREATMENT OR PREVENTION OF KIDNEY DISORDERS AND MEANS FOR THE TREATMENT OR PREVENTION OF ILL. DISEASES

ADSORPTION AGENTS FOR ORAL ADMINISTRATION, MEANS FOR THE TREATMENT OR PREVENTION OF KIDNEY DISORDERS AND MEANS FOR THE TREATMENT OR PREVENTION OF ILL. DISEASES

机译:口服管理吸附剂,肾脏疾病的治疗或预防手段以及疾病的治疗或预防手段。疾病

摘要

An adsorbent for oral administration, characterized by comprising a spherical activated carbon prepared from a thermosetting resin as a carbon source, wherein a diameter is 0.01 to 1 mm, and a specific surface area determined by Langmuir's adsorption equation is 1000 m2/g or more; and an adsorbent for oral administration, characterized by comprising a surface-modified spherical activated carbon prepared from a thermosetting resin as a carbon source, wherein a diameter is 0.01 to 1 mm, a specific surface area determined by Langmuir's adsorption equation is 1000 m2/g or more, a total amount of acidic groups is 0.40 to 1.00 meq/g, and a total amount of basic groups is 0.40 to 1.10 meq/g. The adsorbents for oral administration exhibit a useful selective adsorbability, that is, a less adsorbability of useful substances in a body, and a greater adsorbability of toxic substances.
机译:一种用于口服的吸附剂,其特征在于,包含由热固性树脂制成的球形活性炭作为碳源,其中直径为0.01至1mm,并且由Langmuir吸附方程确定的比表面积为1000m 2 / g。或者更多;以及口服用吸附剂,其特征在于,包含以热固性树脂为碳源的表面改性的球形活性炭,其直径为0.01〜1mm,由朗缪尔的吸附方程式求出的比表面积为1000m <2 > / g以上,酸性基团的总量为0.40〜1.00meq / g,碱性基团的总量为0.40〜1.10meq / g。用于口服的吸附剂表现出有用的选择性吸附性,即,有用物质在体内的吸附性较低,而毒性物质的吸附性较高。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号